NYSE · CIK 0001488917
ELMD Electromed, Inc.
Insider trading from SEC Form 4. Last filing 40 d ago. Close $27.69 on Oct 9, 2026, +20% from the 52-week low and -40% from the high.
Electromed, Inc. (ELMD) has 28 SEC Form 4 filings on file from 9 insiders, the latest filed on Sep 3, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
9 open-market trades have been scored at ELMD. The newest: James L. Cunniff (CEO and President) sold $354k of stock on Jun 8, 2026, filed Jun 9, 2026, scored 33 (weak). The largest of the 9 shown: Kathleen Skarvan (director) sold $4.2M on Nov 18, 2024, scored 78 (notable). 2 insiders sold within 14 days of each other around Jun 8, 2026.
ELMD closed at $27.69 on Oct 9, 2026, 20% above its 52-week low and 40% below its 52-week high.
7 Form 144 notices of planned sales are on file, the latest filed Sep 10, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Electromed, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | James L. Cunniff CEO and President sell | $354k 9,700 shares | -6% | +105% from low-6% from high | |
| 42Moderate | Bradley M. Nagel Chief Financial Officer sell | $429k 11,801 shares | -38% | +103% from low-7% from high | |
| 45Moderate | Kathleen Skarvan director sell | $1.4M 40,000 shares | -53% | +97% from low-2% from high | |
| 60Notable | Andrew Summers director sell | $1.6M 65,714 shares | -100% | +34% from low-33% from high | |
| 58Moderate | Andrew Summers director sell | $3.1M 111,475 shares | -37% | - | |
| 63Notable | Kathleen Skarvan director sell | $2.3M 76,583 shares | -95% | - | |
| 45Moderate | Andrew Summers director sell | $1.1M 37,404 shares | -12% | - | |
| 53Moderate | Andrew Summers director sell | $2.0M 65,630 shares | -19% | - | |
| 78Notable | Kathleen Skarvan director sell | $4.2M 150,000 shares | -103% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 10, 2025 | SVP DEAL FUND 1 LP Affiliate | 65,714 0.79% of outstanding | $1.6M | Sep 10, 2025 | none |
| Feb 20, 2025 | SVP DEAL FUND 1 LP Affiliate | 146,827 1.72% of outstanding | $4.2M | Feb 20, 2025 | $1.5M |
| Feb 20, 2025 | Summers Value Fund LP Affiliate | 50,000 0.58% of outstanding | $1.4M | Feb 20, 2025 | $1.5M |
| Feb 14, 2025 | SKARVAN KATHLEEN Director | 100,000 1.19% of outstanding | $3.2M | Feb 14, 2025 | $4.2M |
| Dec 2, 2024 | SVP DEAL FUND 1 LP Affiliate | 75,000 0.89% of outstanding | $2.3M | Dec 2, 2024 | none |
| Dec 2, 2024 | Summers Value Fund LP Affiliate | 75,000 0.89% of outstanding | $2.3M | Dec 2, 2024 | none |
| Nov 18, 2024 | SKARVAN KATHLEEN Director | 150,000 1.77% of outstanding | $4.3M | Nov 18, 2024 | none |
Transactions
The newest 50 of 82 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Bradley M. Nagel Chief Financial Officer | AGrant or award Common Stock | +4,900 | $0.00 | $0 | 23,864 | 40 d ago |
| Sep 1, 2026 | James L. Cunniff CEO and President | FTax withholding Common Stock | -2,671 | $27.10 | $72k | 145,080 | 40 d ago |
| Sep 1, 2026 | Bradley M. Nagel Chief Financial Officer | FTax withholding Common Stock | -1,102 | $27.10 | $30k | 22,762 | 40 d ago |
| Sep 1, 2026 | Bradley M. Nagel Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +9,600 | $0.00 | $0 | 9,600 | 40 d ago |
| Jun 8, 2026 | James L. Cunniff CEO and President | MOption exercise Common Stock | +9,700 | $17.25 | $167k | 157,451 | Jun 9, 2026 |
| Jun 8, 2026 | James L. Cunniff CEO and President | SOpen-market sale Common Stock | -7,003 | $36.25 | $254k | 150,448 | Jun 9, 2026 |
| Jun 8, 2026 | James L. Cunniff CEO and President | SOpen-market sale Common Stock | -1,671 | $36.80 | $61k | 148,777 | Jun 9, 2026 |
| Jun 8, 2026 | James L. Cunniff CEO and President | SOpen-market sale Common Stock | -1,026 | $37.77 | $39k | 147,751 | Jun 9, 2026 |
| Jun 8, 2026 | James L. Cunniff CEO and President | MOption exercise Employee Stock Option (right to buy)derivative | -9,700 | $0.00 | $0 | 19,400 | Jun 9, 2026 |
| Jun 4, 2026 | Bradley M. Nagel Chief Financial Officer | MOption exercise Common Stock | +4,334 | $10.25 | $44k | 26,172 | Jun 8, 2026 |
| Jun 4, 2026 | Bradley M. Nagel Chief Financial Officer | MOption exercise Common Stock | +5,267 | $10.71 | $56k | 31,439 | Jun 8, 2026 |
| Jun 4, 2026 | Bradley M. Nagel Chief Financial Officer | SOpen-market sale Common Stock | -11,620 | $36.34 | $422k | 19,819 | Jun 8, 2026 |
| Jun 4, 2026 | Bradley M. Nagel Chief Financial Officer | SOpen-market sale Common Stock | -181 | $37.11 | $6,718 | 19,638 | Jun 8, 2026 |
| Jun 4, 2026 | Bradley M. Nagel Chief Financial Officer | MOption exercise Employee Stock Option (right to buy)derivative | -4,334 | $0.00 | $0 | 2,166 | Jun 8, 2026 |
| Jun 4, 2026 | Bradley M. Nagel Chief Financial Officer | MOption exercise Employee Stock Option (right to buy)derivative | -5,267 | $0.00 | $0 | 2,633 | Jun 8, 2026 |
| May 15, 2026 | Kathleen Skarvan director | MOption exercise Common Stock | +40,000 | $3.82 | $153k | 75,622 | May 19, 2026 |
| May 15, 2026 | Kathleen Skarvan director | SOpen-market sale Common Stock | -8,150 | $34.36 | $280k | 67,472 | May 19, 2026 |
| May 15, 2026 | Kathleen Skarvan director | SOpen-market sale Common Stock | -19,032 | $35.24 | $671k | 48,440 | May 19, 2026 |
| May 15, 2026 | Kathleen Skarvan director | SOpen-market sale Common Stock | -9,256 | $36.26 | $336k | 39,184 | May 19, 2026 |
| May 15, 2026 | Kathleen Skarvan director | SOpen-market sale Common Stock | -3,562 | $37.33 | $133k | 35,622 | May 19, 2026 |
| May 15, 2026 | Kathleen Skarvan director | MOption exercise Employee Stock Option (right to buy)derivative | -40,000 | $0.00 | $0 | 0 | May 19, 2026 |
| Dec 1, 2025 | Andrea M. Walsh director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 18,000 | Dec 3, 2025 |
| Dec 1, 2025 | Andrew Summers director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 12,000 | Dec 3, 2025 |
| Dec 1, 2025 | Kathleen Skarvan director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 35,622 | Dec 3, 2025 |
| Dec 1, 2025 | Joseph L. Galatowitsch director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 15,000 | Dec 3, 2025 |
| Dec 1, 2025 | Stan K. Erickson director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 38,817 | Dec 3, 2025 |
| Dec 1, 2025 | Gregory Fluet director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 21,000 | Dec 3, 2025 |
| Dec 1, 2025 | Kathleen A Tune director | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 15,000 | Dec 3, 2025 |
| Sep 10, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SVP Deal Fund I LP | -39,378 | $23.68 | $932k | 26,336 | Sep 12, 2025 |
| Sep 10, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SPV Deal Fund I LP | -16,203 | $25.16 | $408k | 10,133 | Sep 12, 2025 |
| Sep 10, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SPV Deal Fund I LP | -6,576 | $25.94 | $171k | 3,557 | Sep 12, 2025 |
| Sep 10, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SVP Deal Fund I LP | -404 | $26.62 | $11k | 3,153 | Sep 12, 2025 |
| Sep 11, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SPV Deal Fund I LP | -3,153 | $24.42 | $77k | 0 | Sep 12, 2025 |
| Sep 2, 2025 | James L. Cunniff CEO and President | FTax withholding Common Stock | -1,291 | $23.95 | $31k | 130,751 | Sep 4, 2025 |
| Sep 2, 2025 | Bradley M. Nagel Chief Financial Officer | FTax withholding Common Stock | -562 | $23.95 | $13k | 16,538 | Sep 4, 2025 |
| Sep 2, 2025 | James L. Cunniff CEO and President | AGrant or award Common Stock | +17,000 | $0.00 | $0 | 147,751 | Sep 4, 2025 |
| Sep 2, 2025 | Bradley M. Nagel Chief Financial Officer | AGrant or award Common Stock | +5,300 | $0.00 | $0 | 21,838 | Sep 4, 2025 |
| Sep 2, 2025 | James L. Cunniff CEO and President | AGrant or award Employee Stock Option (right to buy)derivative | +31,100 | $0.00 | $0 | 31,100 | Sep 4, 2025 |
| Sep 2, 2025 | Bradley M. Nagel Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +9,800 | $0.00 | $0 | 9,800 | Sep 4, 2025 |
| Feb 20, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By Summers Value Fund LP | -15,689 | $28.71 | $450k | 284,940 | Feb 24, 2025 |
| Feb 20, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By Summers Value Fund LP | -1,947 | $29.81 | $58k | 282,993 | Feb 24, 2025 |
| Feb 20, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SVP Deal Fund I LP | -15,689 | $28.71 | $450k | 131,138 | Feb 24, 2025 |
| Feb 20, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SPV Deal Fund I LP | -1,948 | $29.81 | $58k | 129,190 | Feb 24, 2025 |
| Feb 21, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By Summers Value Fund LP | -11,992 | $28.16 | $338k | 271,001 | Feb 24, 2025 |
| Feb 21, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By Summers Value Fund LP | -734 | $28.99 | $21k | 270,267 | Feb 24, 2025 |
| Feb 21, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SPV Deal Fund I LP | -11,990 | $28.16 | $338k | 117,200 | Feb 24, 2025 |
| Feb 21, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SVP Deal Fund I LP | -735 | $28.99 | $21k | 116,465 | Feb 24, 2025 |
| Feb 24, 2025 | Andrew Summers director | SOpen-market sale Common Stockindirect: By SPV Deal Fund I LP | -50,751 | $27.30 | $1.4M | 65,714 | Feb 24, 2025 |
| Feb 14, 2025 | Kathleen Skarvan director | MOption exercise Common Stock | +40,000 | $1.80 | $72k | 95,394 | Feb 19, 2025 |
| Feb 14, 2025 | Kathleen Skarvan director | FTax withholding Common Stock | -15,178 | $33.21 | $504k | 80,216 | Feb 19, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- James L. CunniffCEO and President
- Stan K. Ericksondirector
- Gregory Fluetdirector
- Joseph L. Galatowitschdirector
- Bradley M. NagelChief Financial Officer
- Kathleen Skarvandirector
- Andrew Summersdirector
- Kathleen A Tunedirector
- Andrea M. Walshdirector
Questions about ELMD
Answered from the filings on this page, as of the latest one.
Are insiders buying ELMD?
No. In the last 90 days no insider at Electromed, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ELMD on the open market?
James L. Cunniff (CEO and President) sold $354k of ELMD on Jun 8, 2026 and filed the Form 4 on Jun 9, 2026. InsiderTell scored 33 (weak), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Electromed, Inc.?
9 people have filed a Form 4 at Electromed, Inc., among them James L. Cunniff (CEO and President), Stan K. Erickson (director), Gregory Fluet (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.